ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
会议论文

Phase 1b study of HS-10241 combined with almonertinib in pre-treated advanced nonsmall cell lung cancer (NSCLC) harboring EGFR mutation

Dong, Xiaorong; Chen, Jianhua; Yu, Yan; Hu, Jie; Li, Xingya; Cheng, Ying; Yao, Wenxiu; Hu, Yanping; Wang, Qiming; Lu, Junguo; Zheng, Wei; Yu, Xinmin; Zhang, Peng; Yu, Zhuang; Wei, Hongying; Li, Chuan; Huang, Qiqi; Tao, Mengyuan; Wu, Qiong; Lu, Shun复旦大学; 华中科技大学; 青岛大学; 哈尔滨医科大学; 郑州大学; 中国医科大学; 1
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)2023-6-1
2阅读
引用收藏
分享
相关
加载中…
  • Adding anlotinib in gradual or local progression on first-line EGFR-TKIs for advanced non-small cell lung cancer: A single-arm, multicenter, phase II trial
    Chen, H.; Hu, Y.; Fan, Y.; Wu, G.; Cang, S.; Yang, Y.; Yang, N.; Ma, R.; Jing, G.; Liu, A.; Xu, X.; Tang, S.; Cheng, Y.; Yu, Y.; Wu, Y-L.
  • A multicenter, randomized, double-blind, phase III study of gefitinib in combination with anlotinib or placebo in previously untreated patients with EGFR mutation-positive advanced non-small cell lung cancer (FL-ALTER)
    Zhang, L.; Fang, W.; Yu, Q.; Zhang, H.; Wu, G.; Wu, D.; Lin, Y.; Zhu, J.; Chen, J.; Hu, X.; Lan, B.; Zhou, Z.; Lin, H.; Wang, Z.; Lei, X.; Pan, S.; Chen, L.; Zhang, J.; Kong, T.; Yu, H.ESMO Asia Congress, Singapore, SINGAPORE, 2022-12-02 To 2022-12-04.
  • Tepotinib plus osimertinib for EGFR mutant (EGFRm) NSCLC with MET amplification (METamp) after first-line (1L) osimertinib
    Tan, Daniel Shao-Weng; Kim, Tae Min; Guarneri, Valentina; Voon, Pei Jye; Lim, Boon Khaw; Wislez, Marie; Huang, Cheng; Liam, Chong Kin; Mazieres, Julien; Tho, Lye Mun; Hayashi, Hidetoshi; Nhung, Nguyen; Chia, Puey Ling; De Marinis, Filippo; Le, Xiuning; Karachaliou, Niki; Brutlach, Sabine; Adrian, Svenja; Ellers-Lenz, Barbara; Wu, Yi-LongAnnual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago, IL, 2023-06-02 To 2023-06-06.
查看全部 →

会议信息

会议名称
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)
会议日期
2023-06-02 至 2023-06-06
论文集名
JOURNAL OF CLINICAL ONCOLOGY
发表日期
2023-06-01
资助标注
Hansoh Pharmaceutical Group Co, Ltd.
收录
ISTP · SCIE

作者

  • D

    Dong, Xiaorong (第一作者)

  • C

    Chen, Jianhua

查看全部 20 位作者收起作者
  • Y

    Yu, Yan

  • H

    Hu, Jie

  • L

    Li, Xingya

  • C

    Cheng, Ying

  • Y

    Yao, Wenxiu

  • H

    Hu, Yanping

  • W

    Wang, Qiming

  • L

    Lu, Junguo

  • Z

    Zheng, Wei

  • Y

    Yu, Xinmin

  • Z

    Zhang, Peng

  • Y

    Yu, Zhuang

  • W

    Wei, Hongying

  • L

    Li, Chuan

  • H

    Huang, Qiqi

  • T

    Tao, Mengyuan

  • W

    Wu, Qiong

  • L

    Lu, Shun

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417